SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $745,000 | +1.5% | 31,442 | +17.7% | 0.14% | +1.5% |
Q3 2019 | $734,000 | -18.8% | 26,714 | -2.2% | 0.14% | -5.6% |
Q2 2019 | $904,000 | -5.5% | 27,326 | 0.0% | 0.14% | +3.6% |
Q1 2019 | $957,000 | +6.0% | 27,326 | +0.4% | 0.14% | +3.7% |
Q4 2018 | $903,000 | -34.0% | 27,204 | 0.0% | 0.13% | -20.2% |
Q3 2018 | $1,369,000 | -24.8% | 27,204 | -10.5% | 0.17% | -24.3% |
Q2 2018 | $1,820,000 | +34.5% | 30,410 | +2.9% | 0.22% | +25.4% |
Q1 2018 | $1,353,000 | +19.0% | 29,556 | +3.5% | 0.18% | +18.0% |
Q4 2017 | $1,137,000 | +8.3% | 28,556 | +8.8% | 0.15% | +4.2% |
Q3 2017 | $1,050,000 | -11.3% | 26,251 | -4.5% | 0.14% | -5.9% |
Q2 2017 | $1,184,000 | +34.5% | 27,478 | -2.3% | 0.15% | +39.1% |
Q1 2017 | $880,000 | +23.9% | 28,128 | 0.0% | 0.11% | +25.0% |
Q4 2016 | $710,000 | +2.2% | 28,128 | 0.0% | 0.09% | -13.7% |
Q3 2016 | $695,000 | -0.1% | 28,128 | -17.7% | 0.10% | +13.3% |
Q2 2016 | $696,000 | -22.1% | 34,188 | -41.6% | 0.09% | -11.8% |
Q1 2016 | $893,000 | -7.6% | 58,588 | -18.5% | 0.10% | -1.9% |
Q4 2015 | $966,000 | -75.6% | 71,930 | -74.5% | 0.10% | -73.3% |
Q3 2015 | $3,963,000 | – | 282,481 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |